The cannabis plant contains more than 460 compounds, at least 80 of which are cannabinoids: active chemical compounds that interact with cannabinoid receptors in the brain and body.
Cannabis and its constituent cannabinoids, such as tetrahydrocannabinol (THC) and cannabidiol (CBD) can be used as a medical therapy to treat various medical conditions.
While CBD is non-psychoactive, it is a therapeutic active phytocannabinoid.
Unlike the psychoactive compound tetrahydrocannabinol (commonly known as THC), CBD not only activates CB1 and CB2 receptors, but also interacts with many other non-endocannabinoid signalling systems such as ion channels and enzymes.
CBD will “talk” to just about every major organ system in the body via the endocannabinoid system, affecting various processes to help restore normal balance and physiological homeostasis.
This explains its therapeutic potential and wide scope of medical applications for patients seeking anti-inflammatory, anxiolytic, analgesic, anti-epileptic, anti-nausea, neuroprotective, and anti-oxidant effects without psychoactive interference.
These are the various medical applications of CBD:
Using full-plant, CBD-rich extracts in their Nutraceutical therapeutic products, Creso Pharma will work towards delivering effective and safe therapeutic options for various diseases and ailments for both humans and pets.